DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
García Ruiz PJ, Cenjor Español C, Sanchez Bernardos V. et al.
Botulinum toxin treatment for spasmodic dysphonia: percutaneous versus transoral
approach.
Clin Neuropharmacol 1998;
21: 196-198
Access:
We do not assume any responsibility for the contents of the web pages of other providers.